1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797631050031038464 |
|---|---|
| author | Sandeep Goyal Avijit Goswami Princy Khurana Kawaljit Singh Aditya Kulkarni Barnali Deb |
| author_facet | Sandeep Goyal Avijit Goswami Princy Khurana Kawaljit Singh Aditya Kulkarni Barnali Deb |
| author_sort | Sandeep Goyal |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:16:31Z |
| format | Article |
| id | doaj.art-738496ec13df49f899c217062ac7e70e |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:16:31Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-738496ec13df49f899c217062ac7e70e2023-11-11T03:10:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.10411041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma modelSandeep Goyal0Avijit Goswami1Princy Khurana2Kawaljit Singh3Aditya Kulkarni4Barnali Deb5New Delhi1Aten Porus Lifesciences, Pvt., Ltd., Bangalore, Karnataka, India3Avammune Therapeutics, Inc., Levittown, PA, USA3Avammune Therapeutics, Inc., Levittown, PA, USA3Avammune Therapeutics, Inc., Levittown, PA, USA1Aten Porus Lifesciences, Bangalore, Karnataka, India |
| spellingShingle | Sandeep Goyal Avijit Goswami Princy Khurana Kawaljit Singh Aditya Kulkarni Barnali Deb 1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model Journal for ImmunoTherapy of Cancer |
| title | 1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model |
| title_full | 1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model |
| title_fullStr | 1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model |
| title_full_unstemmed | 1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model |
| title_short | 1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model |
| title_sort | 1041 discovery of a potential first in class small molecule inhibitor of adar1 p150 which demonstrates strong anti tumor efficacy in b16f10 syngeneic melanoma model |
| work_keys_str_mv | AT sandeepgoyal 1041discoveryofapotentialfirstinclasssmallmoleculeinhibitorofadar1p150whichdemonstratesstrongantitumorefficacyinb16f10syngeneicmelanomamodel AT avijitgoswami 1041discoveryofapotentialfirstinclasssmallmoleculeinhibitorofadar1p150whichdemonstratesstrongantitumorefficacyinb16f10syngeneicmelanomamodel AT princykhurana 1041discoveryofapotentialfirstinclasssmallmoleculeinhibitorofadar1p150whichdemonstratesstrongantitumorefficacyinb16f10syngeneicmelanomamodel AT kawaljitsingh 1041discoveryofapotentialfirstinclasssmallmoleculeinhibitorofadar1p150whichdemonstratesstrongantitumorefficacyinb16f10syngeneicmelanomamodel AT adityakulkarni 1041discoveryofapotentialfirstinclasssmallmoleculeinhibitorofadar1p150whichdemonstratesstrongantitumorefficacyinb16f10syngeneicmelanomamodel AT barnalideb 1041discoveryofapotentialfirstinclasssmallmoleculeinhibitorofadar1p150whichdemonstratesstrongantitumorefficacyinb16f10syngeneicmelanomamodel |